SCHEMBL25008591

SCHEMBL25008591

CC(=O)NCCc1c[nH]c2ccc(C)c(O)c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 15/20 0.59
▸ MTNR1B P49286 14/20 0.59
▸ CYP1A2 P05177 5/20 0.59
▸ BLM P54132 3/20 0.59
▸ NOTUM Q6P988 3/20 0.59
▸ KDM4E B2RXH2 3/20 0.59
▸ CYP3A4 P08684 3/20 0.59
▸ CYP2D6 P10635 3/20 0.59
▸ HPGD P15428 3/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ NPSR1 Q6W5P4 2/20 0.59
▸ MAPT P10636 1/20 0.59
▸ IDO1 P14902 1/20 0.59
▸ SPR P35270 1/20 0.59
▸ NQO2 P16083 4/20 0.56
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ LMNA P02545 1/20 0.56
▸ PKM P14618 1/20 0.56
▸ TSHR P16473 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13644764 0.88 CYP1A2 (0.60) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL31543651 0.84 CYP1A2 (0.59) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL5440846 0.83 MTNR1A (0.72) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL25001166 0.81 MTNR1A (0.76) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL30580919 0.81 MTNR1A (0.76) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL31708170 0.81 HTR2A (0.51) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL25382276 0.80 MTNR1A (0.60) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL31543656 0.80 MTNR1A (0.60) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL31543668 0.80 MTNR1A (0.60) MTNR1AMTNR1BCYP1A2BLMNOTUM
SCHEMBL31543627 0.80 MTNR1A (0.60) MTNR1AMTNR1BCYP1A2BLMNOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043896-A1 HYDROXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING MAGICMED INDUSTRIES INC. (CA) 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043896-A1 HYDROXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING HTR1B, HTR2B, CYP8B1 MTNR1A 758/4885MTNR1B 149/4885CYP1A2 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback